New COVID-19 cases 300 percent higher this Labor Day weekend than last year
Sep 07, 2021
The surge in new cases could really hit a high point in about two weeks from now.
First impressions of a senior living community
By
Lois A. Bowers
Dec 12, 2016
Little things can add up when prospective residents and their families visit a senior living community. And they can mean much to residents living in a community as well. Here are some of the things Senior...
Department of Labor announces virus-related liability protections in light of executive order
By
Amy Novotney
Apr 29, 2020
In a move that may provide leverage in the battle for legal immunity for long-term care providers, the Department of Labor released a statement Tuesday providing some liability protections for meat industry...
Assisted living operators need PPE and testing, should report COVID-19 data to federal government, House...
By
Lois A. Bowers
Jun 26, 2020
Congress should take “immediate steps” to get needed personal protective equipment to assisted living communities, nursing homes, home- and community-based settings and other places where older adults...
Achieving treatment goals in T2DM can up life expectancy
Apr 19, 2022
Life expectancy gains were seen with reducing HbA1c, SBP, LDL-C and BMI among individuals with type 2 diabetes.
Bivalent mRNA-1273.214 elicits better response against omicron
Sep 27, 2022
A booster dose of mRNA-1273.214 elicits more neutralizing antibodies against omicron compared with mRNA-1273, the original Moderna vaccine, with no new safety concerns.
Adding tirzepatide to insulin glargine ups glycemic control in type 2 diabetes mellitus
Feb 10, 2022
For adults with type 2 diabetes and inadequate glycemic control, glycemic control improved with the addition of tirzepatide versus placebo.
More intensive LDL-C lowering may cut recurrent stroke risk
Feb 22, 2022
More intensive LDL-C-lowering with statin-based therapies was linked to a reduced risk for recurrent stroke for patients with evidence of atherosclerosis.
Dopamine agonists, DRIs similar for quality of life in Parkinson’s disease
Dec 29, 2021
The research “suggests that MAO-B inhibitors might be underused as adjuvant therapy for the treatment of people with Parkinson disease.”
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.